Frédéric Lévy
Ludwig Institute for Cancer Research
Lausanne Branch
University of Lausanne
Epalinges
Switzerland
Name/email consistency: high
- Promises and limitations of murine models in the development of anticancer T-cell vaccines. Lévy, F., Colombetti, S. Int. Rev. Immunol. (2006)
- The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases. Lévy, F., Burri, L., Morel, S., Peitrequin, A.L., Lévy, N., Bachi, A., Hellman, U., Van den Eynde, B.J., Servis, C. J. Immunol. (2002)